Blog

How to Read a Peptide Certificate of Analysis Without a Chemistry Background

A plain-language guide to reading a peptide CoA: what the columns mean, which numbers matter, and what a legitimate result looks like.

How to Read a Peptide Certificate of Analysis Without a Chemistry Background

A peptide certificate of analysis is the only document that separates a batch number on a label from verifiable proof of what's inside the vial. Most research buyers encounter these PDFs after purchase, often for the first time, and find themselves staring at chromatography peaks and abbreviations that assume a working knowledge of analytical chemistry. You don't need that background to extract the essential information. What you need is a clear map of which sections matter, which numbers to compare, and which warning signs are visible without a spectrometer or a degree.

Certificates exist because peptide synthesis is not a perfect process. Every batch emerges with the target sequence plus some percentage of truncated chains, deletion variants, and residual salts. The question is always the same: how much of what you ordered is actually present, and how much is something else. A COA answers that question using data from third-party laboratories that run the sample through high-performance liquid chromatography (HPLC) and mass spectrometry. These tests produce numerical outputs. Your task is to read those outputs, verify they match the product description, and decide whether the batch meets your standard.

What a Peptide Certificate of Analysis Actually Contains

A properly issued COA lists the peptide name, batch or lot number, test date, and the laboratory that performed the analysis. The batch number is the thread that ties the document to your vial. Without it, the COA could describe any synthesis run from any month. Match that code to your product label before you assess anything else.

The testing lab's name and location should appear as well. Third-party testing means the manufacturer sent a sample to an independent facility rather than generating the report internally. This separation reduces the incentive to adjust results. Some vendors use the same accredited lab across all batches; others rotate between facilities. Either approach works if the lab's name and methodology are stated clearly.

The methodology section describes which instruments were used: HPLC for purity, mass spectrometry (MS) for molecular weight confirmation. HPLC separates the contents of a sample over time, and the machine plots each component as a peak on a chromatogram. The height and area of the largest peak, relative to all others, determine the purity percentage. Mass spectrometry weighs the molecules to confirm you have the peptide you ordered rather than a close analogue with one amino acid substituted or missing.

Some COAs include additional rows for appearance (white to off-white powder), moisture content, or bacterial endotoxin levels. These matter in specific research contexts but are secondary to purity and molecular weight when you're simply verifying that a batch is what it claims to be.

The Three Numbers That Matter Most

Purity by HPLC is the first number. It appears as a percentage, typically ranging from 95% to 99% or higher for research-grade peptides. This figure represents the proportion of the sample that is the target peptide. The remainder consists of synthesis by-products, primarily shorter peptide fragments and acetate or trifluoroacetate salts left over from purification. A stated purity of 98.2% means 98.2% of the sample is the intended sequence and 1.8% is everything else.

Purity standards vary by application. Some research protocols specify a minimum of 98%, others accept 95%. There is no universal threshold that defines "acceptable" across all contexts. What matters is that the COA's reported purity matches or exceeds the purity grade advertised for that product. If a vendor lists a peptide as ≥98% and the COA shows 97.4%, the batch does not meet the specification.

The second critical number is molecular weight, reported in daltons (Da) or atomic mass units. Every peptide has a known theoretical weight based on its amino acid sequence. The COA lists this expected value and then shows the observed value from mass spectrometry. The two numbers should match within a narrow margin, typically ±1 Da or less. If the theoretical weight is 1528.7 Da and the observed weight is 1529.1 Da, the match is acceptable. If the observed weight is 1543 Da, the peptide sequence is wrong.

Molecular weight is a yes-or-no test. Either the mass matches the target structure or it does not. A batch can have 99% purity and still fail if the molecular weight is off, because that indicates you've received a different peptide entirely, purified to a high standard but chemically incorrect.

The third number is batch size or net peptide content, sometimes listed in milligrams. This tells you how much total material was produced in that synthesis run. It's less critical for verification but confirms the COA refers to a batch of realistic scale. A research supplier synthesising peptides for individual orders will generate batches in the range of a few hundred milligrams to several grams. If a COA lists a batch of 500 grams, it may describe a bulk production run rather than a single-order synthesis, which changes the economic and quality-control context.

Red Flags That Don't Require a Lab Coat

Date mismatches are the most common warning sign. Compare the COA's test date to the batch manufacturing date if provided, and to your order date. A COA dated two years before your purchase may still be legitimate if the vendor is selling from long-term cold storage, but it raises the question of whether the batch has been retested after extended storage. Peptides degrade over time, particularly if stored improperly. A COA from 2023 does not tell you the purity in 2026.

Some vendors supply a single COA for multiple batches by labelling the document with a product code rather than a specific lot number. This practice obscures traceability. If your vial is marked "Batch A4782" and the COA says "Product: Peptide X" with no batch field, you cannot confirm that the tested sample corresponds to your vial. Request a lot-specific COA. If the vendor cannot provide one, assume they're not testing every batch individually.

Generic or template-style COAs with rounded numbers are another signal. Real HPLC purity results are precise: 97.3%, 98.7%, 99.1%. If every COA from a supplier lists exactly 98.0% or 99.0%, the documents may be generated from a template rather than from actual test runs. Analytical instruments produce decimal precision. Whole-number consistency across batches is statistically implausible.

Missing chromatograms or spectra are less obvious but equally important. A complete COA includes the visual output from HPLC (a graph with peaks) and mass spectrometry (a spectrum showing the detected molecular weight). These images allow independent verification. Without them, you are reading a summary table that could be manually typed rather than exported from an instrument. Some legitimate vendors provide abbreviated COAs with only the numerical summary, but the full data should be available upon request.

What Purity Percentage Really Tells You (and What It Doesn't)

Purity measures the proportion of the target peptide in the total sample. It does not measure biological activity, stability, or sterility. A peptide that tests at 99% purity by HPLC could still be functionally degraded if it was synthesised years ago and stored at room temperature. Purity is a snapshot of chemical composition at the moment of testing, not a guarantee of performance in a research setting.

The 1% to 5% that isn't the target peptide consists mostly of truncated sequences and counter-ions. Truncated sequences are shorter versions of the peptide, missing one or more amino acids at the end of the chain. These fragments are chemically similar to the full sequence and are difficult to separate completely during purification. Counter-ions are small charged molecules, often acetate or trifluoroacetate, used to stabilise the peptide in lyophilised form. Both are expected components of any peptide batch.

Some buyers assume higher purity always justifies higher cost. In practice, increasing purity from 98% to 99.5% may require additional purification cycles that double the price while adding marginal benefit for most research uses. The relevant question is whether your protocol is sensitive to the impurities present at a given purity level, not whether a higher percentage exists in theory.

One limitation that remains difficult to assess from a COA alone is the presence of stereoisomers or epimerised residues. Peptides are synthesised from L-amino acids, but certain conditions can cause some residues to flip to the D-form during synthesis or storage. Standard HPLC does not distinguish between L and D isomers; both appear as part of the main peak. Detecting this requires chiral chromatography, which is rarely included in routine COAs. If your research is sensitive to stereochemistry, the standard certificate may not tell you everything you need to know.

Frequently Asked Questions

Can I verify a COA myself without sending the peptide to a lab?

You cannot independently replicate HPLC or mass spectrometry results without access to the same instruments. What you can do is cross-check the COA's internal consistency: confirm the batch number matches your product, verify the molecular weight is correct for the stated peptide sequence, and inspect the chromatogram for a dominant single peak. Visual inspection of the powder (colour, texture) offers limited information but can flag gross contamination such as discolouration or clumping that suggests moisture exposure.

What does it mean if the chromatogram has several small peaks alongside the main one?

Multiple peaks are normal. The main peak represents the target peptide, and smaller peaks represent impurities such as deletion sequences or synthesis by-products. The purity percentage is calculated from the area under the main peak relative to the total area of all peaks. A chromatogram with one large peak at 98% and two small peaks totalling 2% is typical. If the smaller peaks are similar in height to the main peak, purity is lower and the COA should reflect that.

How do I know if the laboratory that issued the COA is trustworthy?

Reputable testing laboratories are often accredited by national or international standards bodies, such as ISO 17025. The COA may list this accreditation. You can also search for the lab's name to verify it operates as an independent commercial facility rather than an in-house department. If the lab name is identical to the vendor name, the testing is not third-party. Some vendors use contract labs that specialise in peptide analysis; these labs often publish client lists or case studies on their own websites.

Does a COA guarantee the peptide is safe for any particular use?

No. A COA documents chemical composition and purity as determined by analytical testing. It does not assess safety, sterility, or suitability for any specific application. All research peptides sold by Titeris and similar vendors are intended for in vitro research use only, not for human or veterinary consumption. The COA confirms what the peptide is, not what it should be used for.

Should I request a new COA if the peptide has been stored for several months?

Peptide stability depends on storage conditions. Most peptides remain stable for months to years when stored as lyophilised powder at –20°C or below, protected from moisture and light. If you've stored a vial under these conditions, the original COA remains a reasonable indicator of purity. If the peptide was stored improperly, particularly after reconstitution or at room temperature, degradation may have occurred and the original COA no longer reflects the current state. Retesting would be the only way to confirm purity after extended or suboptimal storage, but vendors typically do not retest customer-held stock.

Research peptides supplied by Titeris are provided for in vitro research purposes only. These compounds are not medicines, supplements, or treatments. They are not intended for human or veterinary use, and they have not been evaluated by the Medicines and Healthcare products Regulatory Authority. Peptides are sold to qualified researchers and institutions for laboratory investigation. Purchase and handling are restricted to individuals aged 18 or over. Buyers are responsible for ensuring their use complies with applicable local regulations and institutional guidelines.